skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Nome da Publicação: British Journal Of Haematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+ BL and pre‐B‐ALL
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+ BL and pre‐B‐ALL
Material Type:
Artigo 		Adicionar ao Meu Espaço

Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+ BL and pre‐B‐ALL

Awasthi, Aradhana ; Ayello, Janet ; Van de Ven, Carmella ; Elmacken, Mona ; Sabulski, Anthony ; Barth, Matthew J. ; Czuczman, Myron S. ; Islam, Humayun ; Klein, Christian ; Cairo, Mitchell S.

British journal of haematology, 2015-12, Vol.171 (5), p.763-775 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
2
A tale of two antibodies: obinutuzumab versus rituximab
A tale of two antibodies: obinutuzumab versus rituximab
Material Type:
Artigo 		Adicionar ao Meu Espaço

A tale of two antibodies: obinutuzumab versus rituximab

Freeman, Ciara L. ; Sehn, Laurie H.

British journal of haematology, 2018-07, Vol.182 (1), p.29-45 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
3
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients

Pfreundschuh, Michael ; Murawski, Niels ; Zeynalova, Samira ; Ziepert, Marita ; Loeffler, M. ; Hänel, Matthias ; Dierlamm, Judith ; Keller, Ulrich ; Dreyling, Martin ; Truemper, Lorenz ; Frickhofen, Norbert ; Hünerlitürkoglu, Ali‐Nuri ; Schmitz, Norbert ; Pöschel, Viola ; Rixecker, Tanja ; Berdel, Christian ; Rübe, Christian ; Held, Gerhard ; Zwick, Carsten

British journal of haematology, 2017-11, Vol.179 (3), p.410-420 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
4
Rituximab‐induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti‐rituximab antibodies
Rituximab‐induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti‐rituximab antibodies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab‐induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti‐rituximab antibodies

Vendramin, Chiara ; Thomas, Mari ; Westwood, John‐Paul ; McGuckin, Siobhan ; Scully, Marie

British journal of haematology, 2019-03, Vol.184 (5), p.858-861 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
5
Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma
Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma

Chiu, Hsiling ; Trisal, Preeti ; Bjorklund, Chad ; Carrancio, Soraya ; Toraño, Estela G. ; Guarinos, Carla ; Papazoglou, Despoina ; Hagner, Patrick R. ; Beldi‐Ferchiou, Asma ; Tarte, Karin ; Delfau‐Larue, Marie‐Hélène ; Morschhauser, Franck ; Ramsay, Alan G. ; Gandhi, Anita K.

British journal of haematology, 2019-04, Vol.185 (2), p.240-253 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
Pembrolizumab with R‐CHOP in previously untreated diffuse large B‐cell lymphoma: potential for biomarker driven therapy
Pembrolizumab with R‐CHOP in previously untreated diffuse large B‐cell lymphoma: potential for biomarker driven therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab with R‐CHOP in previously untreated diffuse large B‐cell lymphoma: potential for biomarker driven therapy

Smith, Stephen D. ; Till, Brian G. ; Shadman, Mazyar S. ; Lynch, Ryan C. ; Cowan, Andrew J. ; Wu, Qian V. ; Voutsinas, Jenna ; Rasmussen, Heather A. ; Blue, Katherine ; Ujjani, Chaitra S. ; Shustov, Andrei ; Cassaday, Ryan D. ; Fromm, Jonathan R. ; Gopal, Ajay K.

British journal of haematology, 2020-06, Vol.189 (6), p.1119-1126 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
7
Long‐term outcomes of patients treated with rituximab as second‐line treatment for adult immune thrombocytopenia – Follow‐up of the RITP study
Long‐term outcomes of patients treated with rituximab as second‐line treatment for adult immune thrombocytopenia – Follow‐up of the RITP study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long‐term outcomes of patients treated with rituximab as second‐line treatment for adult immune thrombocytopenia – Follow‐up of the RITP study

Tjønnfjord, Eirik ; Holme, Pål André ; Darne, Bernadette ; Khelif, Abderrahim ; Waage, Anders ; Michel, Marc ; Ben Romdhan, Neila ; Ghanima, Waleed

British journal of haematology, 2020-11, Vol.191 (3), p.460-465 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
8
A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study)
A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study)

Rummel, Mathias J. ; Janssens, Ann ; MacDonald, David ; Keating, Mary‐Margaret ; Zaucha, Jan M. ; Davis, Jaclyn ; Lasher, Janet ; Babanrao Pisal, Chaitali ; Izquierdo, Miguel ; Friedberg, Jonathan W.

British journal of haematology, 2021-06, Vol.193 (6), p.1123-1133 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
9
Efficacy of R‐BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy
Efficacy of R‐BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy of R‐BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy

McCulloch, Rory ; Visco, Carlo ; Eyre, Toby A. ; Frewin, Rebecca ; Phillips, Neil ; Tucker, David L. ; Quaglia, Francesca M. ; McMillan, Annabel ; Lambert, Jonathan ; Crosbie, Nicola ; Rule, Simon

British journal of haematology, 2020-05, Vol.189 (4), p.684-688 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
10
Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted EPOCH‐R
Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted EPOCH‐R
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted EPOCH‐R

Giulino‐Roth, Lisa ; O'Donohue, Tara ; Chen, Zhengming ; Bartlett, Nancy L. ; LaCasce, Ann ; Martin‐Doyle, William ; Barth, Matthew J. ; Davies, Kimberly ; Blum, Kristie A. ; Christian, Beth ; Casulo, Carla ; Smith, Sonali M. ; Godfrey, James ; Termuhlen, Amanda ; Oberley, Matthew J. ; Alexander, Sarah ; Weitzman, Sheila ; Appel, Burton ; Mizukawa, Benjamin ; Svoboda, Jakub ; Afify, Zeinab ; Pauly, Melinda ; Dave, Hema ; Gardner, Rebecca ; Stephens, Deborah M. ; Zeitler, William A. ; Forlenza, Christopher ; Levine, Jennifer ; Williams, Michael E. ; Sima, Jody L. ; Bollard, Catherine M. ; Leonard, John P.

British journal of haematology, 2017-12, Vol.179 (5), p.739-747 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (586)
  2. Revistas revisadas por pares (586)

Data de Publicação 

De até
Refinar
  1. Antes de2003  (42)
  2. 2003Até2007  (52)
  3. 2008Até2012  (114)
  4. 2013Até2018  (185)
  5. Após 2018  (199)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.